)
Visual
test
Philogen
Philogen (PHIL) investor relations material
Philogen Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary11 Nov, 2025
Executive summary
Net financial position as of 30 September 2025 is positive at €369.2 million, reflecting a significant increase in liquidity and financial strength.
Major clinical progress reported for Nidlegy™ and Fibromun, with expanded studies and new trials initiated in skin cancers and soft tissue sarcoma.
Stock grant plans for 2024-2026 and 2027-2029 cycles implemented, with partial achievement of performance objectives and new grants allocated.
Financial highlights
Liquidity increased from €100.0 million on 30 June 2025 to €380.3 million on 30 September 2025, up 280%.
Net financial position improved by 317% quarter-over-quarter, mainly due to €299.2 million in customer contract inflows.
Current and non-current financial indebtedness decreased by 2.7% sequentially, primarily from lease amortization.
Outlook and guidance
Strong liquidity enables the launch of new clinical studies and further pipeline expansion.
Plans to initiate a confirmatory Phase III trial for Fibromun in STS with OS as the primary endpoint in 2026.
Preparations underway for a registrational Phase III study of 68Ga-OncoCAIX.
Fibromun STS: rationale for new Phase III?
Source of EUR 299M customer contract inflows?
Nidlegy™ melanoma: new EMA submission strategy?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Philogen
- Strong clinical and regulatory momentum for targeted oncology therapies, with key trial readouts ahead.PHIL
Status Update3 Feb 2026 - Revenues fell sharply, losses widened, but late-stage pipeline and liquidity remain strong.PHILH1 202420 Jan 2026
- Q3 2024 net financial position is €42.96M, with pivotal trials and revenues set for record growth.PHILQ3 202411 Jan 2026
- Revenues tripled, net profit surged, and pivotal oncology trial readouts are due in 2025.PHILH2 202418 Dec 2025
- Licensing deals drove liquidity surge, pipeline progress, and improved financial performance.PHILH1 202526 Sep 2025
- Q1 2025 net financial position at €93.6M, with clinical and R&D progress on track.PHILQ1 20256 Jun 2025
Next Philogen earnings date
H2 202530 Mar, 2026
Philogen
Next Philogen earnings date
H2 202530 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage